Table 5.
Clinicopathological characteristics of 74 breast carcinoma cases stained with RANBP3L.
| Demographic and Clinicopathological Characteristics | Frequency (Percentage) |
|---|---|
| Age | |
| Old (≥55 years) | 41 (55.4) |
| Young (≤45 years) | 33 (44.6) |
| Tumor size | |
| <2 cm | 11 (14.9) |
| >5 cm | 13 (17.6) |
| 2–5 cm | 38 (51.4) |
| Unknown | 12 (16.2) |
| Histopathological grade (Modified Bloom Richardson Grading system) | |
| Grade 1 | 24 (32.4) |
| Grade 2 | 31 (41.9) |
| Grade 3 | 14 (18.9) |
| Unknown | 5 (6.8) |
| Histopathological subtype | |
| Invasive carcinoma, No Special Type (NST) | 62 (83.8) |
| Other subtypes | 12 (16.2) |
| Lymph node positivity | |
| Negative | 27 (36.5) |
| Positive | 31 (41.9) |
| Unknown | 16 (21.6) |
| Progesterone receptor status | |
| Negative | 12 (16.2) |
| Positive | 60 (81.1) |
| Unknown | 2 (2.7) |
| HER-2 expression | |
| Negative | 49 (66.2) |
| Positive | 16 (21.6) |
| Unknown | 9 (12.2) |
| RANBP3L expression | |
| High | 47 (63.5) |
| Low | 27 (36.5) |